MedTrace Logo

Screening for HPV and Cervical Cancer in Young Women With Perinatally Acquired HIV

NCT04587050 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 57

Last updated 2024-12-10

Study results available
· View outcomes & findings →

Summary

This is a cross-sectional, observational study of high-risk HPV status, cervical cytology and HPV vaccine uptake and response in young women with perinatally acquired HIV.

Conditions

Interventions

DIAGNOSTIC_TEST

Human papillomavirus testing

HPV test from cervical sample using Cepheid GeneXpert HPV

DIAGNOSTIC_TEST

Cervical cytology

Cervical cytology

DIAGNOSTIC_TEST

HPV serology

HPV type specific serology (16/18) using ELISA from serum samples

Sponsors & Collaborators

  • Public Health England

    collaborator OTHER_GOV

  • Imperial College London

    lead OTHER

Principal Investigators

  • Tamara Elliott · Imperial College London

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-19
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04587050 on ClinicalTrials.gov